Pemphigus
-
Subject Areas on Research
- A molecular basis for MHC class II--associated autoimmunity.
- A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.
- Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.
- Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase.
- Antibody-induced proteinase activation: a proposed mechanism for pemphigus.
- Basement membrane antibody with skin bullae.
- Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
- Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
- Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris.
- Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
- Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.
- Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
- Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care.
- Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients.
- Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
- Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis.
- Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris.
- Hailey-Hailey disease. Report of a case treated surgically.
- Immunohistochemistry for immunoglobulin G4 on paraffin sections for the diagnosis of pemphigus.
- In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody.
- Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin.
- Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
- Molecular mechanisms of pathogenesis.
- Mucosal erosions and bullae in a child. Pemphigus vulgaris in a child with tinea capitis.
- Neonatal pemphigus vulgaris in a child born to a woman in remission.
- Paraneoplastic pemphigus associated with non-Hodgkin lymphoma.
- Pathogenesis of autoimmunity in pemphigus.
- Penicillamine-induced pemphigus. Immunoglobulin from this patient induces plasminogen activator synthesis by human epidermal cells in culture: mechanism for acantholysis in pemphigus.
- Proteinase activation: a mechanism for cellular dyshesion in pemphigus.
- Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
- Reliability and convergent validity of two outcome instruments for pemphigus.
- Rituximab and low dose oral immune modulating treatment to maintain a sustained response in severe pemphigus patients.
- Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus.
- Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
- The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody.
- Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary report.
- Updates on the management of autoimmune blistering diseases.
- [IgA pemphigus. Successful treatment with mycophenolate mofetil].
- mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.
-
Keywords of People
- Hall III, Russell P., J. Lamar Callaway Distinguished Professor of Dermatology, in the School of Medicine, Integrative Immunobiology